Guangzhou Shenfeng International Trade Co. LTD – Trademark Portfolio

Entity Type: 99

Guangzhou Shenfeng International Trade Co. LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include IVOLIA. The owner is based in Guangzhou, Guangdong.

Room 509-084, 5th Floor

Guangzhou, Guangdong 510000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IVOLIA
IVOLIA
Registered 2022

Trademark Classifications

Guangzhou Shenfeng International Trade Co. LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Guangzhou Shenfeng International Trade Co. LTD have?

Guangzhou Shenfeng International Trade Co. LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Guangzhou Shenfeng International Trade Co. LTD file in?

Guangzhou Shenfeng International Trade Co. LTD files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Guangzhou Shenfeng International Trade Co. LTD's most well-known trademarks?

Guangzhou Shenfeng International Trade Co. LTD's registered trademark portfolio includes well-known marks such as IVOLIA. These are among 1 currently registered trademark in the portfolio.

What is Guangzhou Shenfeng International Trade Co. LTD's trademark registration success rate?

Guangzhou Shenfeng International Trade Co. LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.